Showing 3002 results
-
Event / Oct 23, 2026
-
Biography /
-
Event / Oct 27, 2026Novartis will announce the company’s financial results for the third quarter of 2026.
-
Story /Novartis is working with community partners to bring heart disease and cancer screening, information and support closer to where people are.
-
Press release /In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible…
-
Press release /Late-breaking data from positive Phase III REMODEL-1/-2 trials will show efficacy and safety profile of remibrutinib in RMS Novartis to hold virtual investor event highlighting REMODEL data and…
-
Story /Nazem Atassi, Development Unit Head for Neuroscience and Gene Therapies, Global Drug Development.
-
Clinical Trials /